Inpatient Clinical Pathway for Screening/Evaluation of Children with Suspected 2019 Novel Coronavirus (COVID-19) Disease

Review the Following to Determine Precautions for Patients with Pending SARS-CoV-2 Tests*
  Exposure AGP Precautions
Asymptomatic
(Screening)
No No Standard (Review if precautions for alternate infections are required)
Yes** Expanded; Single negative pressure room, if available. If not able to safely defend in place, transfer to the SIU or PSTU.
Yes No Modified Expanded; Single room with door closed
Yes Expanded; Single negative pressure room, if available. If not able to safely defend in place, transfer to the SIU or PSTU.
Symptomatic
(Diagnostic)
No No Modified Expanded; Single room with door closed
Yes Expanded; Single negative pressure room, if available. If not able to safely defend in place, transfer to the SIU or PSTU.
Yes No Modified Expanded; Single room with door closed
Yes Expanded; Single negative pressure room, if available. If not able to safely defend in place, transfer to the SIU or PSTU.

*If symptoms and/or exposures are unknown/unclear, assume the patient is symptomatic and/or exposed while the test result is pending.

**Asymptomatic and unexposed patients who require an AGP, but have tested negative on admission should remain on standard precautions if repeat testing is needed prior to a procedure.

SARS-CoV-2 Results Available
  No AGP AGP
COVID Positive
  • Expanded
  • Transfer to or remain in SIU or PTSU
  • ID consult
COVID Negative
No Exposure
  • Droplet and/or Contact based on Symptoms
  • Transfer out of the SIU or PSTU, as indicated
COVID Negative
Exposure
  • Expanded for 14 days from date of last exposure
  • Transfer to or remain in SIU, PTSU
Posted: March 2020
Revised: March 2020, April 2020, May 2020, June 2020, July 2020, August 2020, September 2020, October 19, 2020, October 26, 2020
Authors: C. Kerman, MD; D, Davis, MD; K, O’Callaghan, MD; K. Chiotos, MD; J. Lavelle, MD; L. Handy, MD; J. Sammons, MD